Carmichael Hill & Associates, Inc. Novavax Inc Transaction History

Carmichael Hill & Associates, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$134.56 - $217.97 $807 - $1,307	-6 Reduced 46.15%	7 $1,000
Q4 2020 Jan 27, 2021	SELL	$78.74 - $139.5 $551 - $976	-7 Reduced 35.0%	13 $1,000
Q3 2020 Nov 12, 2020	SELL	$79.44 - $178.51 $2,383 - $5,355	-30 Reduced 60.0%	20 $2,000
Q2 2020 Aug 05, 2020	BUY	$13.86 - $83.61 $693 - $4,180	50 New	50 $4,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $629M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.